Knowledge Center

Articles

ESG & Innovation

En savoir plus

ESG & Innovation

Driving Sustainable Progress in R&D

Laurent Petit - Head of Innovation and External Collaboration

As we approach the dawn of 2025, the intersection of Environmental, Social, and Governance (ESG) principles with innovation has never been more critical. Our company has been at the forefront of integrating ESG into our research and development (R&D) processes, setting ambitious goals and pioneering new methodologies to ensure sustainable progress. This article outlines our journey, key initiatives, and the impact of our efforts on the broader industry.

Read the article

API supply chain resilience by design

En savoir plus

API supply chain resilience by design

Didier Combis - Marketing and Commercial development Head

Didier Combis of EUROAPI looks at why considering the API value chain can strengthen the global medicine supply chain.

Read the article

Case studies

CDMO Case study - Driving continuous improvement

En savoir plus

CDMO Case study - Driving continuous improvement

EUROAPI OPTIMIZES PHASE 3 PROCESS FOR SMALL MOLECULE PROJECT

The R&D Small Molecules Team in Frankfurt has successfully developed an efficient process to support a Phase 3 CDMO project with a smallsized company. The initial technical package included four steps and produced the API with a 52% overall yield and a PMI (Process Mass Intensity) of 159.

Read the case study

Posters

Advances in peptide synthesis

En savoir plus

Advances in peptide synthesis

Advances in peptide synthesis with green chemistry and cutting-edge technologies

Read the poster

Videos

The Dexamethasone

En savoir plus

The Dexamethasone

OUR CONTRIBUTION

Dexamethasone is a vital active pharmaceutical ingredient, widely used in emergency care for its powerful anti-inflammatory effects. It plays a key role in the treatment of critical conditions, especially in intensive care settings — including severe respiratory distress, septic shock, cerebral edema, and acute allergic reactions.

Beyond emergency use, it is also essential in managing autoimmune diseases, certain cancers, and chronic inflammatory conditions.

Through advanced scientific expertise and seamless collaboration across teams, we ensure this essential API remains reliably available, consistently high-quality, and proudly manufactured in Europe.

Read the video

White papers

Enzyme production for biocatalysis application

En savoir plus

Enzyme production for biocatalysis application

Recombinant Transaminase Case Study

From miniaturized scale to pilot plant (10m3 ): the Brindisi development approach

Read the white paper